TP53 and cancer: Here, we observe that 12 samples from six different cancer types are mutated in the 52 bps that make up the splice sites of TP53. These splicing mutations are highly significant (q = 1.2 × 10−21, ncdDetect), and might lead to inactivation of the tumor suppressor TP53 gene (Eicheler et al., 2002).